ASX ANNOUNCEMENT22 June 2021IDT Receives First Commercial...

ASX ANNOUNCEMENT22 June 2021IDT Receives First Commercial Shipment of Medicinal Cannabis Flower through a Commercial Partnership with Clever Leaves _____________________________________________________________IDT Australia Limited (ASX: IDT) provides the following market update.IDT Australia Limited and Clever Leaves Holding Inc. (NASDAQ: CLVR, CLVRW) today jointly announced a commercial partnership for Clever Leaves to supply to IDT two varieties of bulk GACP1 certified medicinal cannabis flower from Clever Leaves’ facility in Portugal.As part of the commercial partnership, Clever Leaves has made its first commercial shipment of its high-THC dried flower to IDT Australia. IDT will package the flowerin its cGMP certified facility, which will then undergo stability assessment. Pending the successful completion of stability trials, IDT will launch this cGMP medicinal cannabis flower-in-bottle product through Australian distributors. IDT cGMP medicinal cannabis flower products will complement the Company’s pre-existing medicinal cannabis processing, extraction and conversion to finished dosage form activities.IDT Australia is an expert partner in the production and manufacture of pharmaceutical products, including medicinal cannabis. Currently, many of patients are unable to access their prescribed cannabis-based medicines, whilst the current1 Good Agricultural and Collection PracticesAbout IDTIDT (ASX:IDT) is an Australian pharmaceutical manufacturing company based in Boronia, Victoria, Australia. The Company has extensive experience in the development and production of high potency and high containment pharmaceutical products for local and international clients. IDT’s facilities are cGMP compliant and are regularly audited by the US FDA and Australian TGA. With an experienced team of specialists within world- class facilities, IDT provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. shortage has also hit almost every Australian distributor. Clever Leaves’ partnership with IDT will aid in the relief of the ongoing medicinal cannabis flower shortage in Australia.“Clever Leaves’ supply agreement with IDT is a great step forward to begin facilitation of high-quality products for those in need in Australia and we could not be more thrilled to be a part of the process,” said Kyle Detwiler, CEO of Clever Leaves. “With the Clever Leaves’ Portugal facility operating commercially, the company is now open for business, providing Australians with additional medical cannabis flower products and the ability to meet the patient demand.”“Australia currently has limited access to quality and affordable cGMP medicinal cannabis flower products for patients in need. Clever Leaves is a dependable and reputable supplier which meets IDT’s stringent cGMP requirements and we see this partnership as a strategic solution which creates a great opportunity for both companies,” said IDT’s CEO Dr David Sparling.Ends..../IDTAuthorised by the Board of Directors of IDT Australia Limited. For further information please contactr David SparlingChief Executive Officer - IDT Australia Limited+61 3 9801 8888